I-025

Interference Mix 3 (For Qualitative Use Only)

50-1000 μg/mL each component in acetonitrile, analytical standard, Cerilliant^®

• Synonyme(s) : Qualitative Interference Mixture
• Code UNSPSC : 41116107
• Nomenclature NACRES : NA.24

Propriétés

• Qualité: analytical standard
• Forme: liquid
• Composition: Aripiprazole, 100 μg/mL ; Lacosamide, 100 μg/mL ; Oxcarbazepine, 100 μg/mL ; (+)-Propoxyphene, 50 μg/mL ; Rufinamide, 100 μg/mL ; Warfarin, 1000 μg/mL
• Conditionnement: ampule of 1 mL
• Fabricant/nom de marque: Cerilliant^®
• drug control: estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)
• Concentration: 50-1000 μg/mL each component in acetonitrile
• Technique(s): gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• Application(s): forensics and toxicology
• Format: multi-component solution
• Température de stockage: −20°C

Description

Description générale

A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs (+)-propoxyphene; aripiprazole; lacosamide; oxcarbazepine; rufinamide; and warfarin. This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory′s analytical methods.

Informations légales

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Informations sur la sécurité

• Pictogrammes: GHS02,GHS08,GHS07
• Mention d'avertissement: Danger
• Mentions de danger: H225,H302 + H312 + H332,H319,H360D,H373
• Conseils de prudence: P210 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P312 - P308 + P313
• Classification des risques: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2 - Repr. 1A - STOT RE 2
• Organes cibles: Blood
• Code de la classe de stockage: 3 - Flammable liquids
• Classe de danger pour l'eau (WGK): WGK 2
• Point d'éclair (°F): 35.6 °F - closed cup
• Point d'éclair (°C): 2.0 °C - closed cup